214 related articles for article (PubMed ID: 25870611)
1. Evaluation of CA125 and NT-proBNP values in patients undergoing transcatheter aortic valve implantation.
Ayhan H; Kasapkara HA; Durmaz T; Keleş T; Sarı C; Baştuğ S; Erdoğan KE; Bayram NA; Bilen E; Akçay M; Bozkurt E
J Geriatr Cardiol; 2015 Mar; 12(2):100-6. PubMed ID: 25870611
[TBL] [Abstract][Full Text] [Related]
2. Impact of N-terminal pro-B-type natriuretic peptide response on long-term prognosis after transcatheter aortic valve implantation for severe aortic stenosis and heart failure.
Kaneko H; Hoelschermann F; Tambor G; Okamoto M; Neuss M; Butter C
Heart Vessels; 2019 May; 34(5):777-783. PubMed ID: 30443765
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of N-terminal pro-B-type natriuretic peptide in patients with normal left ventricular ejection fraction undergoing transcatheter aortic valve implantation.
Seoudy H; Kuhn C; Frank J; Eden M; Rangrez AY; Lutter G; Frey N; Frank D
Int J Cardiol; 2020 Feb; 301():195-199. PubMed ID: 31757644
[TBL] [Abstract][Full Text] [Related]
4. Different impact of aortic regurgitation assessed by aortic root angiography after transcatheter aortic valve implantation according to baseline left ventricular ejection fraction and N-terminal pro-B-type natriuretic peptide.
Kaneko H; Hoelschermann F; Schau T; Tambor G; Neuss M; Butter C
Cardiovasc Interv Ther; 2018 Jul; 33(3):232-238. PubMed ID: 28567700
[TBL] [Abstract][Full Text] [Related]
5. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation.
Ribeiro HB; Urena M; Le Ven F; Nombela-Franco L; Allende R; Clavel MA; Dahou A; Côté M; Laflamme J; Laflamme L; DeLarochellière H; DeLarochellière R; Doyle D; Dumont E; Bergeron S; Pibarot P; Rodés-Cabau J
Am J Cardiol; 2014 Mar; 113(5):851-9. PubMed ID: 24528616
[TBL] [Abstract][Full Text] [Related]
6. Post-procedural N-terminal pro-brain natriuretic peptide predicts one-year mortality after transcatheter aortic valve implantation.
Vale NC; Campante Teles R; Madeira S; Brito J; Sousa Almeida M; Nolasco T; Abecasis J; Rodrigues G; Carmo J; Furstenau M; Ribeiras R; Neves JP; Mendes M
Rev Port Cardiol (Engl Ed); 2018 Jan; 37(1):67-73. PubMed ID: 29317115
[TBL] [Abstract][Full Text] [Related]
7. Is elevation of N-terminal pro-B-type natriuretic peptide at discharge associated with 2-year composite endpoint of all-cause mortality and heart failure hospitalisation after transcatheter aortic valve implantation? Insights from a multicentre prospective OCEAN-TAVI registry in Japan.
Mizutani K; Hara M; Nakao M; Okai T; Kajio K; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
BMJ Open; 2018 Aug; 8(8):e021468. PubMed ID: 30121598
[TBL] [Abstract][Full Text] [Related]
8. Baseline NT-proBNP Accurately Predicts Symptom Response to Transcatheter Aortic Valve Implantation.
Allen CJ; Joseph J; Patterson T; Hammond-Haley M; McConkey HZR; Prendergast BD; Marber M; Redwood SR
J Am Heart Assoc; 2020 Dec; 9(23):e017574. PubMed ID: 33241754
[TBL] [Abstract][Full Text] [Related]
9. Assessment of left ventricular function with tissue Doppler echocardiography and of B-type natriuretic peptide levels in patients undergoing transcatheter aortic valve implantation.
Yüksel IO; Arslan S; Cagirci G; Koklu E; Ureyen CM; Bayar N; Kucukseymen S; Kus G; Guven R
Rev Port Cardiol; 2017 May; 36(5):377-383. PubMed ID: 28495181
[TBL] [Abstract][Full Text] [Related]
10. The evolution and prognostic value of N-terminal brain natriuretic peptide in predicting 1-year mortality in patients following transcatheter aortic valve implantation.
Elhmidi Y; Bleiziffer S; Piazza N; Ruge H; Krane M; Deutsch MA; Hettich I; Voss B; Mazzitelli D; Lange R
J Invasive Cardiol; 2013 Jan; 25(1):38-44. PubMed ID: 23293174
[TBL] [Abstract][Full Text] [Related]
11. Does residual aortic regurgitation after transcatheter aortic valve implantation increase mortality in all patients? The importance of baseline natriuretic peptides.
Borz B; Durand E; Godin M; Tron C; Canville A; Hauville C; Bauer F; Cribier A; Eltchaninoff H
Int J Cardiol; 2014 May; 173(3):436-40. PubMed ID: 24679693
[TBL] [Abstract][Full Text] [Related]
12. Periprocedural Changes of NT-proBNP Are Associated With Survival After Transcatheter Aortic Valve Implantation.
Seoudy H; Frank J; Neu M; Güßefeld N; Klaus Y; Freitag-Wolf S; Lambers M; Lutter G; Dempfle A; Rangrez AY; Kuhn C; Frey N; Frank D
J Am Heart Assoc; 2019 Feb; 8(3):e010876. PubMed ID: 30686097
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Carbohydrate Antigen 125 and N-Terminal Pro-Brain Natriuretic Peptide for Risk Prediction After Transcatheter Aortic Valve Implantation.
Rheude T; Pellegrini C; Schmid H; Trenkwalder T; Mayr NP; Joner M; Kasel AM; Holdenrieder S; Nunez J; Sanchis J; Bodi V; Schunkert H; Kastrati A; Hengstenberg C; Husser O
Am J Cardiol; 2018 Feb; 121(4):461-468. PubMed ID: 29306485
[TBL] [Abstract][Full Text] [Related]
14. Meta-Analysis of Impact of Baseline N-TerminalPro-Brain Natriuretic Peptide Levels on SurvivalAfter Transcatheter Aortic Valve Implantation for Aortic Stenosis.
Takagi H; Hari Y; Kawai N; Kuno T; Ando T;
Am J Cardiol; 2019 Mar; 123(5):820-826. PubMed ID: 30587374
[TBL] [Abstract][Full Text] [Related]
15. Elevated growth differentiation factor 15 levels predict outcome in patients undergoing transcatheter aortic valve implantation.
Krau NC; Lünstedt NS; Freitag-Wolf S; Brehm D; Petzina R; Lutter G; Bramlage P; Dempfle A; Frey N; Frank D
Eur J Heart Fail; 2015 Sep; 17(9):945-55. PubMed ID: 26230285
[TBL] [Abstract][Full Text] [Related]
16. CA125 outperforms NT-proBNP in acute heart failure with severe tricuspid regurgitation.
Soler M; Miñana G; Santas E; Núñez E; de la Espriella R; Valero E; Bodí V; Chorro FJ; Fernández-Cisnal A; D'Ascoli G; Marti-Cervera J; Sanchis J; Bayes-Genís A; Núñez J
Int J Cardiol; 2020 Jun; 308():54-59. PubMed ID: 32209267
[TBL] [Abstract][Full Text] [Related]
17. Rise and fall of NT-proBNP in aortic valve intervention.
Hultkvist H; Holm J; Svedjeholm R; Vánky F
Open Heart; 2018; 5(1):e000739. PubMed ID: 29632678
[TBL] [Abstract][Full Text] [Related]
18. Baseline NT-proBNP predicts acute kidney injury following transcatheter aortic valve implantation.
Eckrich K; Mangner N; Erbs S; Woitek F; Kiefer P; Schlotter F; Stachel G; Leontyev S; Holzhey D; Borger MA; Linke A; Haussig S
Cardiovasc Revasc Med; 2024 Mar; ():. PubMed ID: 38599917
[TBL] [Abstract][Full Text] [Related]
19. Differential Prognostic Value of Galectin-3 According to Carbohydrate Antigen 125 Levels in Transcatheter Aortic Valve Implantation.
Rheude T; Pellegrini C; Núñez J; Joner M; Trenkwalder T; Mayr NP; Holdenrieder S; Bodi V; Koenig W; Kasel AM; Schunkert H; Kastrati A; Hengstenberg C; Husser O
Rev Esp Cardiol (Engl Ed); 2019 Nov; 72(11):907-915. PubMed ID: 30482731
[TBL] [Abstract][Full Text] [Related]
20. Early changes in N-terminal pro-B-type natriuretic peptide levels after transcatheter aortic valve replacement and its impact on long-term mortality.
Liebetrau C; Gaede L; Kim WK; Arsalan M; Blumenstein JM; Fischer-Rasokat U; Wolter JS; Kriechbaum S; Huber MT; van Linden A; Berkowitsch A; Dörr O; Nef H; Hamm CW; Walther T; Möllmann H
Int J Cardiol; 2018 Aug; 265():40-46. PubMed ID: 29885699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
